The Consortium Health Technology Assessment Agencies and Payers Committee provides a global platform for analysts, researchers, and managers from assessment agencies, government health policymakers, and individuals from public or private health payers to discuss and debate issues related to all health products (including drugs and medical devices and diagnostics), as well as health policy issues, lessons-learned, and experiences in healthcare policy making and implementation.

Consortium members may participate in working committees. Please contact us.

Chair

Alexander Kostyuk, PhD MD

President at Kazakhstan ISPOR Chapter, Kazakh Assotiation of HTA, EBM & HEOR
Almaty, AKM, Kazakhstan

Past Chair

Jitendar Sharma, PhD PhD

Executive Director, Kalam Institute of Health Technology
Visakhapatnam, India

HTA Committee Members


Jeonghoon Ahn, PhD PhD MA

Associate Professor, Ewha Womans University
Seoul, South Korea

Alima Almadiyeva, MD MPH

CEO, Kazakh Agency for Health Technology Assessment
Nur-Sultan (Astana), AKM, Kazakhstan

Toshiaki Baba, MD

MSc student, LSE
London, United Kingdom

Shiva Naga Vara Prasad Bathula, MS RPh BS PhD

Food & Medical Product Safety Research Scientist, U.S. Food and Drug Administration
New Delhi, India

Nilakantha Bhoi, MBA PharmD BSc

WHO technical Consultant, Procurement & Supply Chain Management (PSM), Ministry of Health & Family Welfare, Govt. of India
New Delhi, India

Mounica Bollu, PharmD

chalapathi institute of pharmaceutical sciences
guntur, India

Nancy Chen

ISPOR
Lawrenceville, NJ, United States

MELANIE CORONEL, MD

MEDICAL SPECIALIST, PHILIPPINE HEALTH INSURANCE CORPORATION
PASIG CITY, Philippines

Karapet Davtyan, MD MPH

Head of Monitoring and Evalution department of National TB Program, National Tuberculosis Control Office of Ministry of Health of Armenia
Yerevan, Armenia

Gereltuya Dorj, MSc PhD

Lecturer, Mongolian National University of Medical Sciences
Ulaanbaatar, Mongolia

Jagadeswara Rao Earla, MBA PharmD

Doctoral Student & Teaching Assistant, University of Houston College of Pharmacy
Houston, TX, United States

Ruoyan Gai, MSc PhD

Senior Research Officer, National Institute of Population and Social Security Research
Tokyo, 13, Japan

Erie Gusnellyanti

Head of Section for Monitoring and Evaluation of Rational Use of Medicines, Directorate of Pharmaceutical Services, Ministry of Health of Indonesia
South Jakarta, Indonesia

Neppali Jagadeesh, PharmD

Clinical Pharmacist, fortis Healthcare limited
mumbai, India

Bhavesh Jain, MSc

Senior Advisor, Health Financing, Abt Associates
Mumbai, India

Isao Kamae, DrPH MD

Project Professor, Health Policy and Technology Assessment, The University of Tokyo
Tokyo, 13, Japan

Mehrnaz Kheirandish, PhD MD

Tehran University of Medical Sciences
Tehran, Iran

Sukyeong Kim, RPh PhD MPH

Senior Research Fellow, National Evidence-based Healthcare Collaborating Agency (NECA)
Seoul, South Korea

Chanda Kulkarni, PhD MD

Mrs., SAKRA World Hospital
Bangalore, KA, India

Temirkhan Kulkhan

HTA Department, Republican Center for Health Development of the Ministry of Health and Soci
Astana, Kazakhstan

Hye-Young Kwon, PhD PhD BSc MPH

Assistant professor, Mokwon University
seoul, South Korea

Cheng-Hua Lee, DrPH MD

Deputy Director General, National Health Insurance Administration, Taiwan
Taipei, Taiwan

Nicky Liebermann, MD

Head of Medical Policy Division, Clalit Health Services
Tel Aviv, TA, Israel

Liang Lin, BSc

Singapore

Eswaran Maheswari, PhD

Professor, Faculty of Pharmacy
Bangalore, India

Agnette P. Peralta, MBA

Director, Bureau of Health Devices and Technology
Mexico City, Mexico, Mexico

Raoh-Fang Pwu, MS PhD

Director, NHCP Office, MOHW
Taipei, Taiwan

Mohanraj Rathinavelu, PharmD

ASSOCIATE PROFESSOR, RAGHAVENDRA INSTITUTE OF PHARMACEUTICAL EDUCATION & RESEARCH, RIPER
Anantapuramu, India

Farhan Abdul Rauf, PhD MD MPH

Director of Programs & Services, Our Own Public Health Institute (OOPHI)
Karachi, Pakistan

Juan Rodriguez, BA

Medical Manager, Compensar
Bogota, Colombia

Robert Selby, MBA BA

Director, Global Networks, Asia Pacific and Latin America, ISPOR
Lawrenceville, NJ, United States

HU SHANLIAN, MSc MD

SHANGHAI HEALTH DEVELOPMENT RESEARCH CENTER
SHANGHAI, 31, China

Mohd Fazli Shuib, MBA RPh

Manager, Clinical Research, Pharmacoeconomics and Clinical Assignments, Prince Court Medical Centre
Kuala Lumpur, Malaysia

W Robert Simons, PhD

Normandy Beach, NJ, United States

Fatemeh Soleymani, PharmD PhD MPH

Assistant Professor, Tehran University of Medical Sciences
Tehran, Iran

Mariam Sraj, PharmD

Beirut, BA, Lebanon

Pei Keow Tan, MSc

Senior Principal Assistant Director, Ministry of Health Malaysia
Petaling Jaya, Malaysia

Yen-Huei (Tony) Tarn, MS PhD

Director, ZTE Foundation HTA Center
Taipei, TPE, Taiwan

Madeleine R. Valera

Senior Vice President HTA Department, Philippine Health Insurance Corporation
Pasig City, Philippines

Wan Mohd Hamidi Wan Sulaiman, MS RPh BSc

Lecturer, Cyberjaya University College of Medical Sciences
Cyberjaya, Malaysia

Bong-Min Yang, PhD

Seoul, South Korea

Marzhangul Zeityn, MBA MD

Kazakhstan

Jie Zhang, BS

Project Manager, China Health Insurance Research Association
Beijing, China

Yingjiao Zhao, PhD

Researcher, National Healthcare Group
Singapore, Singapore

Kun Zhao

Director, China National Health Development Research Centre
Beijing, China
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×